SANUWAVE Health, Inc. Business Acquisition, Pro Forma Net Income (Loss)
SANUWAVE Health, Inc. (SNWV) reported Business Acquisition, Pro Forma Net Income (Loss) of -$35.60 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-05-13
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2020-12-31 was -$11.73M.
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2020-09-30 was -$12.55M.
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2019-12-31 was -$367.30K.
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2019-09-30 was -$4.86M.
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2020 was -$35.60M.
- SANUWAVE Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2019 was -$15.22M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$11.73M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-13 | -$24.28M derived: sum of 2 quarters · filed 2022-05-13 | -$35.60M 10-K · filed 2022-05-13 | -$35.53M 10-K · filed 2021-10-21 | |||
| 2020-09-30 | -$12.55M 10-Q/A · filed 2021-07-01 | -$5.42M 10-Q · filed 2020-11-23 | -$23.87M 10-Q/A · filed 2021-07-01 | -$16.74M 10-Q · filed 2020-11-23 | |||
| 2019-12-31 | -$367.30K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-10-21 | -$5.23M derived: sum of 2 quarters · filed 2021-10-21 | -$15.22M 10-K · filed 2021-10-21 | ||||
| 2019-09-30 | -$4.86M 10-Q/A · filed 2021-07-01 | -$14.86M 10-Q/A · filed 2021-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |